In the last trading session, 0.11 million shares of the Telomir Pharmaceuticals Inc (NASDAQ:TELO) were traded, and its beta was -0.05. Most recently the company’s share price was $2.10, and it changed around -$0.1 or -4.55% from the last close, which brings the market valuation of the company to $62.50M. TELO currently trades at a discount to its 52-week high of $8.40, offering almost -300.0% off that amount. The share price’s 52-week low was $1.98, which indicates that the current value has risen by an impressive 5.71% since then.

Telomir Pharmaceuticals Inc (NASDAQ:TELO) trade information

Instantly TELO has showed a red trend with a performance of -4.55% at the end of last trading. The performance over the last five days has remained in the red territory. The rise to weekly highs of 2.60 on recent trading dayincreased the stock’s daily price by 19.23%. The company’s shares are currently down -49.03% year-to-date, but still down -16.00% over the last five days. On the other hand, Telomir Pharmaceuticals Inc (NASDAQ:TELO) is -17.97% down in the 30-day period.

TELO Dividends

Telomir Pharmaceuticals Inc’s next quarterly earnings report is expected to be released in June.

GEODE CAPITAL MANAGEMENT, LLC, with 0.2241% or 66355.0 shares worth $0.32 million as of 2024-06-30, holds the second largest percentage of outstanding shares.

VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund and iShares Trust-iShares Russell 2000 ETF were the top two Mutual Funds as of Dec 31, 2024 . The former held 833.23 shares worth $1.75 million, making up 2.80% of all outstanding shares. On the other hand, iShares Trust-iShares Russell 2000 ETF held roughly 456.89 shares worth around $0.96 million, which represents about 1.54% of the total shares outstanding.